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Abstract
The purpose of this quality improvement project was to increase physical activity among
postoperative adult liver transplant patients, improve documentation of daily activity, and
ultimately influence quality of life (QOL). Quality of life has been shown to improve
dramatically after liver transplant, as patients enter transplant severely debilitated with
limitations on their physical activity which carry over following transplant. The literature
supports that liver transplant patients should engage in physical activity which may improve
QOL. Thirteen liver transplant patients were recruited within the seven days of their postoperative hospitalization. Twelve patients consented, were educated about the benefits of
walking, given instructions for how to gradually increase their walking activity, and how to track
this activity in a daily log. The International Physical Activity Questionnaire (IPAQ) that
calculates level of physical activity (metabolic equivalent or MET score) was conducted at
baseline and six weeks. Patients were also asked to rate their perceived quality of life on a ten
point scale. Eight patients completed the study with four patients medically unable to complete
the walking program. Baseline MET and QOL scores were compared between Time 1 and Time
2 (six weeks). The IPAQ baseline score increased from 407.5 MET to 1,711.5 MET, however,
results were not statistically significant. Quality of life improved from Time 1 average score of
5.5 (SD=2.51) to Time 2 average score of 8.25 (SD=1.67) and was statistically significant
(P=0.27). Liver transplant patients gradually increased their walking activity over a six week
period and documented that activity daily. QOL was also purported to increase which is
consistent with findings in the literature. Implementing a post liver transplant walking program
is feasible and beneficial for patients and should be a standard of care.
Keywords: liver transplant, physical activity, exercise, quality of life

Chapter One: Introduction
Over 129,000 people living in the United States have undergone liver transplant since
creation of the United Network for Organ Sharing (UNOS) database in 1988. Currently, there
are approximately 15,690 people on the liver transplant waiting list and anticipating the lifesaving procedure (UNOS, 2014). Long-term outcomes of liver transplant have continued to
improve over the past decades, with survival rates in the 80-90% range today (Masala et al.,
2012). Liver transplant recipients have high expectations of getting their life back as they once
knew it. Now that the management of transplant recipients has been refined and clinical
outcomes improved over the past decades, quality of life (QOL) has become more of a focus of
clinicians and patients alike. QOL has been shown to improve dramatically after liver transplant,
however, is inferior to those in the general population (van den Berg-Emons et al., 2006b).
Common hindrances to achieving a high QOL include fatigue, low level of physical activity,
inability to work, and mental health diagnoses to include anxiety or depression (Masala et al.,
2012). Research has demonstrated that increased physical activity is associated with a higher
QOL in those with chronic diseases (Painter, 2008).
This chapter will discuss the epidemiology related to chronic liver disease, challenges the
transplant recipient faces including complications of liver disease affecting QOL in the pre- and
postoperative period, pharmacologic and metabolic influences in the transplant patient, an
abbreviated literature review related to QOL, the problem and purpose to be addressed in this
quality improvement project, and a definition of terms.
Chronic Liver Disease
Chronic liver disease ranks 12th as the cause of death in the United States
(Perumalswami & Schiano, 2011). Over the past 20 years, liver transplantation has been
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increasingly warranted partly due to the rising trend of obesity, which may lead to non-alcoholic
steatohepatitis (NASH), an increased number of patients developing hepatocellular carcinoma
(HCC), and a rising number of people who are co-infected with hepatitis C and human
immunodeficiency virus (HIV) (Perumalswami & Schiano, 2011). The principal indication for
liver transplantation is hepatitis C-related cirrhosis with many ultimately developing HCC
(Merion, 2010). With new hepatitis C therapies that inhibit polymerase and protease proteins
coming on the market (Klenerman and Gupta, 2012), NASH may soon become the number one
indication for transplant. Other primary indications for transplant include cholestatic liver
diseases such as primary biliary cirrhosis or primary sclerosing cholangitis, autoimmune liver
disease, hepatocellular carcinoma, and acute liver failure. The increasing need for liver
transplantation will likely continue in the foreseeable future (Merion, 2010).
Challenges and Complications of Liver Transplantation
By the time transplant candidates receive their new organ, many are severely debilitated,
muscle wasted, malnourished, and unable to engage in regular physical activity. Many
individuals have been suffering for long periods of time with liver disease complications,
including severe fatigue, hepatic encephalopathy, portal hypertension, ascites, gastrointestinal
bleeding, spontaneous bacterial peritonitis (SBP), other infections such as cellulitis, and renal
insufficiency (Perumalswami & Schiano, 2011). The road back to general health, well-being,
and optimal QOL post-transplant is a long one compared to the average healthy person.
Fatigue is a pervasive symptom that affects persons with liver disease. One study
reported that 44% of patients complain of severe fatigue up to more than a decade post-transplant
which may cause the most distress the first year following their transplant (van Ginneken et al.,
2007). A high level of fatigue in liver transplant patients has been shown to be significantly
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correlated with poorer QOL (Rodrigue, Nelson, Reed, Hanto, & Curry, 2010). A study by van
den Berg-Emons et al. (2006a) suggested that the fatigue experienced by liver transplant patients
is attributed to physical factors as opposed to psychological factors. The authors of this study
also found that persons with fatigue generally did not engage in regular physical activity. A
possible downward spiral of physical activity leading to increased fatigue may exist, which leads
to further reduction in activity and increasing fatigue (van Ginneken et al., 2007).
Ascites is the most common complication of cirrhosis and carries a 20% mortality rate in
one year (Zipprich et al., 2012). Ascites stems from physiologic changes caused by portal
hypertension (Perumalswami & Schiano, 2011). Patients have difficulty ambulating or engaging
in regular exercise due to swelling of the legs and an uncomfortable swollen abdomen which can
cause shortness of breath. Difficulty in exercising negatively impacts the patient post-transplant
as well, in that they are more severely deconditioned and have a more challenging pathway to
achieving physical fitness and a higher QOL.
Patients with liver disease commonly have other complications that preclude them from
exercising on a regular basis, and the impact of these complications often times carries over posttransplant. Thirty percent of patients with ascites develop spontaneous bacterial peritonitis,
which is the common type of infection in those with cirrhosis (Perumalswami & Schiano, 2011).
These infections frequently are recurrent, carry a 50% one-year mortality rate, and require
hospitalization and antibiotic treatment, which hinders one’s ability to exercise and negatively
impacts QOL.
Patients may also suffer from cardiopulmonary dysfunction. Approximately a quarter
develop hepatopulmonary syndrome and about 10% develop pulmonary hypertension (Hoeper,
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Krowka, & Strassburg, 2004). These conditions can manifest as worsening shortness of breath
with exertion and hypoxia. These symptoms greatly impede one’s physical activity and QOL.
Hepatic encephalopathy is another common complication found in liver disease patients.
It is associated with mental status changes, personality changes, and memory and cognitive
deficits (Perumalswami & Schiano, 2011). Patients with worsening encephalopathy require
hospitalization and have difficulty participating in regular exercise due to their mental debility.
Liver transplant patients must take powerful immunosuppressive agents such as
Prednisone, which contributes to weight gain, specifically from increased fat as opposed to lean
muscle mass (Everhart et al., 1998). One study demonstrated approximately 28% of liver
transplant recipients were obese with a body mass index greater than 30 (McGuire et al., 2009).
In addition, steroid use is associated with higher cholesterol and very low density lipoprotein
measurements (Kobashigawa & Kasiske, 1997). Maintaining an ideal body weight and
participating in regular exercise while on immunosuppressive therapy can present yet another
challenge for the liver transplant patient.
Quality of Life
In spite of complications, the clinical outcomes of liver transplantation have been
improving and clinicians and patients are focusing on improving post-transplantation QOL. If
one does not experience a high QOL following transplant, in addition to decreased mortality,
then the patient may contemplate whether the surgery was worth it. Even though QOL improves
for those who have undergone transplant, those in the general population experience a higher
QOL than their transplant counterparts (Masala et al., 2012). Many liver transplant recipients are
unable to return to their same level of pre-illness functioning (Riether, Smith, Lewison, Cotsonis,
& Epstein, 1992). Issues which negatively impact QOL such as fatigue, rheumatoid-type

5

symptoms, and general debility may continue to affect patients (Masala et al., 2012). Some
transplant recipients have achieved a high level of post-transplant fitness such as the athletes
competing in the Transplant Games (Krasnoff et al., 2006).
Validated and reliable tools to measure QOL have been used in research studies. The
well-known Short Form-36 (SF-36) (Ware, 1992) is a questionnaire that the patient completes on
his or her own. It contains four physical scales and four mental scales. The physical scales
include Physical Functioning (limitations perceived about the ability to carry out physical
activities), Role-Physical (role limitations due to physical health), Bodily Pain, and General
Health (perceptions about health and potential changes in health). The mental scales include
Vitality (perceptions about level of energy), Social Functioning (limitations perceived about the
ability to carry out social activities), Role-Emotional (perceptions about activity limitations
related to emotional issues), and Mental Health (feelings of anxiety or depression) (Rongies et
al., 2011; Van Ginneken et al., 2010). The Physical Composite score is calculated from the four
physical scales and the Mental Composite score from the four mental scales. Scores are
computed on a scale from zero to 100, with a higher score correlated with a higher QOL. All of
the studies reviewed in this paper utilized the SF-36 or the Dutch version of the same instrument,
the RAND-36.
Liver Transplantation, Physical Activity and Quality of Life
There appears to be strong evidence to support that QOL improves following liver
transplant. In addition, a literature review suggests that increased physical activity is associated
with improved QOL. The International Physical Activity Questionnaire (IPAQ) is a valid and
reliable self-reporting instrument that measures physical activity in adults (Craig et al., 2003) and
has been utilized in studies related to QOL and physical activity (Masala et al., 2012). Seven
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recent articles pertaining to QOL and its relationship with physical activity in the liver transplant
patient will be reviewed in Chapter 2. An overview of the studies reveals that those liver
transplant patients who engaged in physical activity were more likely to score higher on the
various scales of the SF-36 or RAND-36.
Clinical Problem
In the immediate postoperative period following transplant, patients receive daily
physical therapy as part of their hospital care. Some are discharged in as little as five days, and
they are encouraged to follow physical therapy guidelines which mainly focus on safe transfers
and ambulating in a safe manner, not physical activity. Physical activity recommendations at
time of discharge from receiving a liver transplant or at their follow-up clinic visit include: avoid
lifting greater than 10 pounds; avoid strenuous activity such as golf, swimming or aerobics;
walking is encouraged but do not use a treadmill; avoid steep inclines; and increase walking
activity each day. They are typically not required to keep a diary of their physical activity.
Patients oftentimes go into transplant severely debilitated and deconditioned with
limitations on their physical activity which carryover following transplant. Therefore, it may
take several weeks to months for these patients to increase their activity enough to achieve a
recommended level of regular exercise. In addition, patients may not know about the importance
of physical activity post-surgery and the positive association with quality of life. A physical
activity prescription for walking could assist patients to achieve optimal QOL.
Patients and their caregivers are supplied with a large binder at the time of transplant and
are required to keep track of all medications, blood pressure readings, and blood sugar readings.
However, they are not required to record their daily physical activity. Providing a physical
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activity prescription and including a physical activity log in the patient binder would be a
strategy to encourage patients to resume physical activity and consequently improve their QOL.
Purpose
The purpose of the project was to assess and apply the evidence related to improving
QOL in liver transplant patients through making recommendations for physical activity and
evaluating the result of this quality improvement practice change in the clinical setting. The
project set out to explore if adult liver transplant patients who are provided with physical activity
(walking) instructions would increase their physical activity from baseline to six weeks. Three
secondary questions were also addressed: 1) Will adult liver transplant patients document their
daily physical activity on an activity log? 2) Will adult liver transplant patients who participate in
this walking program perceive an increased QOL from baseline to six weeks? 3) What is the
optimal time following liver transplant to start a walking program?
Definition of Terms
MELD Score
The Model for End-Stage Liver Disease or MELD Score is based on a patient’s
creatinine, international normalized ratio (INR), and total bilirubin. The range of MELD score is
from 6-40, with a higher score indicative of further decompensation of liver disease and higher
mortality.
MET Score as Calculated by the IPAQ
Metabolic equivalent (MET) score relates to average minutes spent engaging in physical
exercise per week (Masala et al., 2012). The International Physical Activity Questionnaire
(IPAQ) calculates the MET score by asking participants the days and minutes exercised in three
categories of intensity (vigorous, moderate, and walking) during the previous one week. The
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following formula is used to calculate the MET: MET = 8(vigorous activity)(minutes) +
4(moderate activity)(minutes) + 3.3(walking activity) (minutes).

Quality of Life (QOL)
A feeling of happiness, well-being, and satisfaction with one’s life status (Molzahn,
1991). QOL is frequently measured by The Medical Outcomes Study Short Form-36 (SF-36), a
valid and reliable instrument which contains four physical health scales (Physical Functioning,
Role-Physical, Bodily Pain, and General Health), four mental health scales (Vitality, Social
Functioning, Role-Emotional, and Mental Health), and two composite scales (Physical
Composite and Mental Composite) that are related to overall QOL.
Summary
As a result of excellent clinical outcomes following liver transplant, quality of life (QOL)
has become a key focus for care providers and patients alike. QOL improves after liver
transplant but has, unfortunately, been found to be inferior compared to the general population
(Masala et al., 2012). For patients with chronic diseases, studies have indicated increased
physical exercise is associated with a higher QOL (Painter, 2008). Common obstacles to
achieving a superior QOL following transplant include fatigue, inability to maintain
employment, decreased levels of physical activity, and mental health issues such as depression or
anxiety (Masala et al., 2012). Newly transplanted patients are discharged in as little as five days
with only minimal recommendations provided to them regarding physical activity. The purpose
of this project is to implement a protocol into post-operative care of patients that increases
physical activity among adult liver transplant patients to improve their QOL.
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Chapter Two: Review of Literature
This chapter describes the search process and synthesizes the literature related to physical
activity and quality of life in the liver transplant patient. Quality of life is defined, seminal
studies are identified, and studies are discussed in relationship to interventions and outcomes.
The strength of the evidence is appraised and application of the findings to clinical practice are
discussed.
Search Strategy
A literature search pertaining to the effectiveness of physical activity on improving QOL
in liver transplant patients was performed utilizing the PICO question: Do adult liver transplant
patients (P) who engage in regular physical activity (I) as compared to their sedentary
counterparts (C) enjoy a higher quality of life (O)? Search terms included: liver transplant,
quality of life, exercise, and physical activity. Databases used in the search included CINAHL,
Cochrane Library, One Search, Academic Search Complete, Science Direct, and MedlineProquest. A search was also carried out for practice guidelines on the American Association for
the Study of Liver Diseases (AASLD) website. In addition, a search for practice guidelines was
conducted on the Agency for Healthcare Research and Quality (AHRQ).
A total of 1,379 individual studies initially were listed after the key search words were
entered into the various databases that related to the PICO question. Exclusion criteria were
applied to narrow the search to studies that pertained to the PICO question. Articles were
excluded for reasons including wrong patient population (for example, pediatric patients or other
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organ transplant recipients), research only on QOL or only on physical activity, and lower level
studies like qualitative and case studies. The search was further limited to English language and
those studies conducted between 2000 and 2012. No systematic reviews or clinical practice
guidelines were found that pertained to physical activity in liver transplant patients or quality of
life in liver transplant patients. A few older studies are reviewed as well that laid the
groundwork for subsequent research. A total of seven studies were retained for the purposes of
this review. They included one randomized trial control study, one non-randomized
interventional pre-post study, two case-control studies, and three cross-sectional studies.
Defining Quality of Life
QOL has often been defined as a feeling of happiness, well-being, and satisfaction with
one’s life status (Molzahn, 1991). A great body of research has been done on QOL in the past
quarter of a century, with only 117 studies written in the early 1990’s to greater than 3,500
studies in 2005 (Denny & Kienhuis, 2011). Denny and Kienhuis utilize the crisis theory
framework in explaining QOL in transplant patients. Erich Lindemann’s (1944) research on
management of grief gave rise to the crisis theory, which proclaims that people need
psychological balance in order to effectively cope with problems. The theory purports that crisis
interferes with this psychological balance, and individuals need to call on new ways of coping
that may be beyond their comfort level in order to restore balance. The theory can be applied to
patients awaiting transplant as being in crisis who must develop coping strategies and
subsequently applied to post-transplant patients who have maintained their QOL despite having
undergone physical and mental challenges (Denny & Kienhuis, 2011).
A meta-analysis on QOL after liver transplant was carried out in 1999 and published in
the official AASLD journal Liver Transplantation and Surgery (Bravata, Olkin, Barnato, Keeffe,

11

& Owens, 1999). The authors reviewed 15 research studies that included a total of 3,576
patients and utilized consistent QOL scales. The analysis revealed a significantly positive
improvement following liver transplant in the areas of physical health, daily activities, general
health-related QOL, sexual functioning, and social functioning. The largest improvements were
noted in the physical functioning realms and lesser improvements in the mental functioning
realms (Bravata et al., 1999). The findings in this meta-analysis align with other studies
evaluating QOL from pre-transplant to post-transplant in other types of organ recipients (i.e.,
heart, kidney, and lung), with greater gains in QOL noted in the physical scales than the
psychological scales (Bravata et al., 1999).
Seminal Studies Related to Physical Activity in Transplant Patients
Patricia Painter, PhD. is a pioneer in research on exercise in the transplant patient. Some
of her earlier research was carried out on renal transplant patients in the mid 1980’s, where she
examined the effects of physical activity on patients who were on dialysis (Painter et al., 1986).
In the late 1990’s, she conducted research on the aerobic capacity and health-related QOL of
athletes who participated in the 1996 United States Transplant Games. Subsequently, she and
her colleagues conducted a study evaluating the effectiveness of physical activity on improving
QOL in only liver transplant patients (Painter, Krasnoff, Paul, & Ascher, 2001).
In Dr. Painter’s study on the effects of physical activity on renal transplant patients, she
found a significant improvement in maximum oxygen uptake in the interventional group, with no
change observed in the control group (Painter et al., 1986). Her work with transplant athletes
who had received a wide variety of organs and who participated in the 1996 Transplant Games
revealed that the athletes had a significantly higher aerobic capacity than the inactive control
group, attaining an average 95% of age-predicated aerobic capacity. In addition, the athletes had
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higher levels of QOL as measured by the SF-36 and had less body fat when compared to their
sedentary counterparts (Painter et al., 1997).
In her later work (Painter, Krasnoff, Paul and Ascher, 2001) in evaluating the
effectiveness of physical activity on improving QOL in liver transplant patients, those who
engaged in regular exercise scored significantly higher on all of the SF-36 physical scales. In
addition, after comorbidities such as diabetes and heart disease, gender, age, time since
transplant, and hepatitis C recurrence were all factored out in the regression model, it was found
that physical exercise was an independent predictor of the SF-36 physical functioning and
component scales.
Dr. Painter has written extensively about promoting exercise in the transplant patient as
part of routine management and care (Painter, 2005). She has discovered through her research
that less than one-third of liver transplant recipients actually engage at a level of activity that the
Surgeon General has recommended (Krasnoff & Painter, 2002). She argues that the reasons
regular exercise is recommended for the general population also apply to the transplant patient,
including managing hypertension and reducing risk of heart disease. Also, exercise can play an
important role in the transplant population specifically by attenuating the side effects (i.e.,
hyperglycemia and hypercholesterolemia) of immunosuppressant medications (Painter, 2005).
Impact of Physical Activity on QOL in Liver Transplant Patients
Although QOL in liver transplant patients has been well documented and expert opinion
strongly recommends physical activity, only seven studies were identified for this literature
review. The purpose of the group of the seven studies was to explore the relationship between
physical activity or physical fitness and QOL in liver transplant recipients. The studies’ settings
were dispersed throughout the world: three in the Netherlands, two in the United States, one in
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Poland, and one in Italy. The total combined sample size from all articles was 539 patients, with
sample sizes ranging from 16 to 180 patients. Length of time since transplant varied from two
months to 17 years. Among the seven studies, one included patients who were between two and
12 months post-transplant, one included patients who were between six and 36 months posttransplant, four studies with patients between one and eight years post-transplant, and one study
that focused on fatigued patients between one and 17 years post-transplant. Despite the wide
range of time since surgery, liver transplant patients share commonalities across the board,
including experiencing the effects of immunosuppression, comorbidities such as kidney disease
or diabetes, and possibly recurrent liver disease (Masala et al., 2012).
Interventions
The two interventional studies (Krasnoff et al., 2006; van Ginneken et al. (2007)
employed walking, aerobics, strength training, and counseling sessions. In addition, a home
exercise prescription was provided to participants, goals were set, and daily activity logs were
given in the Krasnoff et al. (2006) study. The other five studies employed an accelerometer, the
6-minute walk test, strength and aerobic tests, and questionnaires to determine level of fitness or
activity.
Physical activity measures. The seven studies measured physical activity or fitness
either by direct observation or by patient report. Four out of the seven studies employed physical
activity monitoring or supervised exercise training with direct observation (Krasnoff et al., 2006;
Van den Berg-Emons et al., 2006b; Van Ginneken et al., 2007; Van Ginneken et al., 2010). The
three remaining studies relied on participant self-report of physical activity (Masala et al., 2012;
Painter et al., 2001; Rongies et al., 2011). Painter et al. (2001) stressed that patients’ self-report
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of physical activity has been shown to be reliable and significantly predicts clinical outcomes
such as mortality.
The International Physical Activity Questionnaire (IPAQ) was used in one study (Masala
et al., 2012) to approximate physical activity and derives a metabolic equivalent score (MET).
The MET score is calculated based on the average number of minutes patients spend engaging in
three categories physical activity intensity (vigorous, moderate, and walking) during the previous
one week. The formula is as follows: [MET = 8(vigorous activity)(minutes) + 4(moderate
activity)(minutes) + 3.3(walking activity)(minutes)].
Quality of life measures. All seven studies measured QOL using the psychometricallytested Medical Outcomes Study Short Form-36 (SF-36) or the Dutch version of the same
instrument, the RAND-36. The SF-36/RAND-36 is a valid and reliable internationally-used
instrument that consists of four physical health scales (Physical Functioning, Role-Physical,
Bodily Pain, and General Health), four mental health scales (Vitality, Social Functioning, RoleEmotional, and Mental Health), and two composite scales (Physical Composite and Mental
Composite). The two composite scales provide an overall assessment of the four physical and
four mental scales. Scores can range from a low QOL of 0 to a high QOL of 100.
Outcomes
Despite the variety of ways in which physical activity or fitness was measured, all seven
studies found significant associations or improvements in at least two scales of the SF-36 or
RAND-36. Table 1 displays the design, sample, outcomes measured, intervention, and results of
the seven studies. Table 2 breaks down each scale of the SF-36/RAND-36 and shows the ones
that were either significantly associated with or significantly improved with physical activity or
fitness. Four out of seven studies showed significant associations between level of physical
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activity or fitness and four or more scales of the QOL instrument (Masala et al., 2012; Painter et
al., 2001; Rongies et al., 2011; Van Ginneken et al., 2007) among participants who were 3.3 to 8
years post-transplant. Two studies (Van den Berg-Emons et al., 2006b; Krasnoff et al., 2006)
showed a significant improvement or association in two or three of the QOL scales among
participants who were between two and 36 months post-transplant.
The two interventional studies (Krasnoff et al., 2006; van Ginneken et al., 2010) showed
significant improvements in two scales of the QOL instrument. Possible reasons why the
Krasnoff et al. study realized improvements in only two scales include the fact that the exercise
program was of low intensity, frequency, and duration (i.e., exercise three times per week or
more and work up to at least 30 minutes at a time). The authors also reported that only 69% of
participants followed the exercise recommendations. In the Van Ginneken et al. (2010) study the
authors surmised that their 12-week intervention program was perhaps too short to appreciate a
significant change in the other scales of the RAND-36. In addition, the training only took place
twice a week on weeks one, four, eight and 12.
Significant associations between level of physical activity or fitness and at least three out
of eight scales of the QOL instrument were noted in the other five studies (Masala et al., 2012;
Painter et al., 2001; Rongies et al., 2011; Van den Berg-Emons et al., 2006b; Van Ginneken et
al., 2007). In the Masala et al. (2012) study, metabolic equivalent (MET) was significantly
correlated with all of the SF-36 scales, including the Physical Composite and Mental Composite
scales (P ≤ .011). However, when a multiple regression analysis was carried out, the condition
of having a liver transplant was negatively correlated with the Physical Functioning (β = -12.479;
P = .001), Role-Physical (β = -17.181; P = .006), Role-Emotional (β = -16.158; P = .006), Mental
Health (β = -8.070; P = .010), and Mental Composite (β = -3.087; P = .043) scales of the SF-36.
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This correlates with prior research indicating that even though QOL improves after liver
transplant, it is still inferior to those in the general population (Van den Berg-Emons et al.,
2006b).
In conclusion, the seven studies reviewed were consistent in their findings with each
other and with prior research. Six out of seven studies found a significant change or association
between physical activity or fitness and the Physical Functioning scale of the SF-36/RAND-36
QOL instrument (Masala et al., 2012; Painter et al., 2001; Rongies et al., 2006; Van Ginneken et
al., 2007; Van Ginneken et al., 2010). Four of the seven studies found a significant change or
association between physical activity or fitness and the General Health (Krasnoff et al., 2006;
Masala et al., 2012; Painter et al., 2001; Rongies et al., 2011), Vitality (Masala et al., 2012;
Painter et al., 2001; Van Ginneken et al., 2007; Van Ginneken et al., 2010), and Bodily Pain
(Masala et al., 2012; Painter et al., 2001; Van Ginneken et al., 2007) scales of the SF-36/RAND36. Of note, the Physical Functioning scale score is derived from 10 out of the 36 questions of
the SF-36/RAND-36 and, thus, carries the most weight in determining overall QOL. The
General Health scale, with five questions out of 36, is the second most-weighted scale in the
QOL instrument.
Strength of the Evidence
A summary of the level of evidence and research designs is presented in Table 2. Levels
of evidence were determined using the scale published by Melnyk and Fineout-Overholt (2005).
Level I evidence includes systematic reviews or evidence-based guidelines. Level II evidence
includes RCT studies. Level III evidence includes nonrandomized control trials (quasiexperimental). Level IV evidence includes case-control and cross-sectional studies. Levels V,
VI, and VII evidence includes systematic reviews of qualitative studies, a single qualitative
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study, and expert opinion, respectively. The purpose of appraising the evidence is to discern
what level of evidence exists to support a change in practice to recommend regular exercise in
order to improve QOL for liver transplant patients.
Out of the seven studies reviewed, one was a randomized control trial (RTC) (Krasnoff et
al., 2006). One was a quasi-experimental uncontrolled study (Van Ginneken et al., 2010).
Three-out-of seven studies had control groups (Krasnoff et al, 2006; Van den Berg-Emons et al.,
2006a; Masala et al., 2012). Most of the studies had small sample sizes with less than 30
participants while three studies included between 119 and 180 participants.
The highest level of evidence was the RCT by Krasnoff et al. (2006). The Jadad scale
was employed to evaluate the quality of this study (Jadad et al., 1996). The Jadad scale has
excellent reliability and validity and has been found to be superior to other scales (Olivo et al.,
2008). Seven items are included in calculating the overall score of 0 to 5:
1. Randomization (yes = 1, no = 0).
2. Method of randomization described (yes = 1, no = 0).
3. Double blind study (yes = 1, no = 0).
4. Description of dropouts (yes = 1, no = 0).
5. Deduction of one point if method for randomization was inappropriate (described but
inappropriate = -1, described and appropriate = 0).
6. Deduction of one point if method of blinding was inappropriate (described but
inappropriate = -1, described and appropriate = 0).
According to this scale, the Krasnoff et al. RCT has a score of 2 out of 5. Points were taken off
for number two and number three of the scale. It is difficult, however, to blind participants and
investigators when exercise is the intervention as opposed to a new drug.
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Limitations among these studies included small sample sizes, lack of randomization, and
lack of control groups. Some studies noted that not all participants adhered to the treatment
program with level of education noted as a distinguishing characteristic in one study. Findings
from these seven level II-IV studies suggests that engaging in regular physical activity among
liver transplant patients may improve QOL.
Table 2
Studies by Level of Evidence From Highest to Lowest
Level of evidence

# of Studies

Study

II – RTC

1

Krasnoff et al. (2006)

III – Non-randomized
Experimental Study

1

Van Ginneken et al. (2010)

IV – Case-Control

2

Masala et al. (2012)
Van den Berg-Emons (2006a)

IV – Cross-sectional

3

Painter et al. (2001)
Rongies et al. (2011)
Van Ginneken et al. (2007)

Melnyk, B. & Fineout-Overholt, E. (2005). Evidence-based practice in nursing &
healthcare: a guide to best practice/ Bernadette Mazurek Melnyk and Ellen FineoutOverholt. Philadelphia: Lippincott Williams & Wilkins, c2005 (i.e. 2004).
Implications of the Evidence
This review of the literature suggests that recommending regular physical activity (twoto-three times weekly or at least 30 minutes) to liver transplant patients may be associated with
improved QOL. QOL is valued by patients who are living longer with serious chronic illness
and wish to optimize their health and well-being. Liver transplant patients are at a greater
disadvantage physically and aerobically compared to the general population due to their use of
immunosuppressive agents, metabolism derangement with possible diabetes, weight gain,
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general deconditioning, and fatigue (van Ginneken et al., 2007). Hence, liver transplant patients
have a greater need for physical rehabilitation and exercise, which should be encouraged by
clinicians. Although higher level studies are needed to bolster the relationship between QOL and
physical activity among liver transplant patients, there are no contraindications for patients to
gradually engage in physical activity as a general prescription for improved health.
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Chapter Three: Methods
This chapter includes a description of the design, setting and sample for this evidencebased quality improvement project. This is followed by a discussion of the methods and
procedures for the project, including the protection of human subjects. The purpose of this
quality improvement project was to increase physical activity among postoperative adult liver
transplant patients, improve documentation of daily activity, and influence quality of life.
Design
This project was a single-subject design with every participant serving as his or her own
control. Data was collected through patient interview and analysis of patient recorded activity
log at baseline and at six weeks. Demographic, process, and outcome data was collected.
Outcome related to physical activity was measured by the International Physical Activity
Questionnaire (IPAQ). Patients were asked to rate their perception of their QOL, on a scale of 1
(low) to 10 (high) with an opportunity to elaborate on their answer. This was used in lieu of the
SF-12 to reduce response burden among patients who were very ill and debilitated.
Population and Setting
Adult patients aged 18-65 who received a liver transplant at a nationally recognized
transplant center in the southeast were considered for the project. From this pool of patients,
those who were between five and 21 days post liver transplant and who were approved by a
hepatologist and/or transplant surgeon were ultimately invited to participate in the project.
Exclusion criteria were as follows: Patients who had active infections, encephalopathy or
cognitive dysfunction, who were recipients of a combined liver-kidney transplant, who had
severe debility, or who required assistance to ambulate. Potential candidates for the project were
identified by the hospital clinical coordinators during the time a patient was hospitalized for liver
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transplant. In addition, patients attending routine follow-up visits in the Liver Transplant
Department at Mayo Clinic were considered for the project.
Procedure
Once it was determined that a patient met the inclusion criteria for participation, details
of the project were reviewed with them. They were informed that the project was entirely
voluntary and that if they chose to participate, they could withdraw at any time from the project
for any reason. They were informed that their decision did not impact their receiving the usual
postoperative care. A written informed consent (see Appendix A) was thoroughly reviewed with
each patient. Ample time was provided for them to review the written information on the
consent, and they were invited to ask any questions they had about the project. Once the patients
agreed to participate, signatures were obtained on the consent form.
Patients included in the project were advised about the important benefits of engaging in
regular physical activity. The principal investigator (PI) utilized the Five A's Behavior Change
Model (Assess, Advise, Agree, Assist and Arrange) (Registered Nurses' Association of Ontario,
2010) as a guide to help motivate the participants to incorporate a walking program into their
daily activity (see Appendix B). The participants were provided the following physical activity
walking instructions: Walk 5-10 minutes each day. Increase your walking by 5 minutes every 3
days. Your goal is to reach 30 minutes of walking for at least 5 days per week. The walking
instructions are aligned with the American Heart Association’s (2014) recommendations to
exercise five-to-six days of the week for a total of 150 minutes per week. Participants were
encouraged to walk at their level of tolerance and advised to increase their walking by five
minutes every three days until reaching a total of 30 minutes per day or 150 minutes per week.
An activity log (see Appendix C) was placed in the patient's transplant log book so they could
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record the number of minutes spent walking each day. This section of the log book included a
summary of the health benefits of walking at the top of the activity log, as well as warning signs
such as excessive fatigue, pain, or shortness of breath. The PI discussed the walking program
and reviewed documentation for the notebook. Participants were advised they could break up
their walks into shorter segments throughout the day. They were instructed on how to take their
pulse and what a safe heart rate range is during exercise. They were invited to call the clinic
should they have any questions or needed additional guidance.
Prior to starting the exercise program, the PI requested the patient answer the seven
questions on the IPAQ which measures their current level of physical activity. The IPAQ
questionnaire is a widely utilized instrument that contains seven items to help calculate the
Metabolic Equivalent (MET) (Masala et al., 2012). It has acceptable validity and reliability in a
number of countries when compared to other self-administered questionnaires (Craig et al.,
2003). It includes questions about minutes and days spent during the prior week in vigorous
activity (VA), moderate activity (MA), and walking activity (W). As mentioned in Chapter One,
The MET is calculated as follows: MET = 8*VA (d*min) + 4*MA (d*min) + 3.3W (d*min).
The score on this tool was used as a baseline score. The patient was also asked to reflect on their
current quality of life: "On a scale of 0-10, what would you say is your quality of life at this
time?" The answer to this question was recorded on an attachment to the IPAQ questionnaire.
At six weeks, the PI talked with the participants, either in person or on the telephone, to
assess their progress in the walking program. At this time, the PI asked the participants to
answer the IPAQ and QOL questions again and recorded the minutes walked per day from their
activity logs. All raw data was collected in a manila file folder and kept in a secured locked
cabinet. Raw data was de-identified and entered into an Excel file that was stored in a password-
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protected computer. Each patient was given a unique identifier when data was transferred into
the Excel file. Dates were not recorded, rather, time increments were indicated as Time 1 and
Time 2.
Data Collection and Analysis
Participants were enrolled and data collected over a five-month period spanning from
April 15th to September 6th of 2014. Demographic information was collected at project onset,
including age, gender, Model for End-Stage Liver Disease (MELD) score at time of transplant,
diagnosis/indication for transplant, comorbidities, if intensive care unit (ICU) stay was required
during time of transplant, and length of hospital stay. This information was used to describe the
project’s population. The IPAQ and QOL scores were recorded at baseline and at six weeks.
Activity logs were reviewed to explore patterns of physical activity among the participants.
The JMP Pro version 9.0.1 was utilized (Sall, 2010) for data analysis. Descriptive
statistics included counts, frequencies, percentages, means and standard deviation (SD).
Comparisons were made between IPAQ and QOL scores at baseline and at six weeks using the
Wilcoxon Matched-Pairs Signed Ranks test. This nonparametric test was utilized due to the low
sample size and scores that were not normally distributed.
Feasibility
The project is feasible since there is an accessible pool of liver transplant recipients
currently being cared for on an ongoing basis at the clinic. The PI is an advanced practice
registered nurse clinician at this center. In addition, the clinic is a research-based facility and
encourages a culture of quality improvement, to implement best evidence into practice, and to
ultimately improve clinical outcomes.
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Protection of Human Subjects
Permission to carry out this study was obtained from the principle investigator’s project
committee, the Institutional Review Board for the University of North Florida, and the
Institutional Review Board for Mayo Clinic, Jacksonville, Florida. Participants of the study were
thoroughly briefed of essential information pertaining to the study, including potential benefits
and risks. Written informed consent was reviewed and signed by each participant prior to
beginning the walking program.
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Chapter Four: Results
This chapter reports the findings from the project and describes the participants and their
experience with the walking program. Tables outlining demographic information of each
participant, scores from the IPAQ tool, and scores from the QOL question were compared.
Participant Demographics
During the project recruitment period, 13 liver transplant patients were available for
study recruitment and were within the first seven days of post liver transplant. Twelve patients
consented to participate while one patient refused. Of those 12, four patients were not able to
continue and had to be dropped. One patient could not participate in physical activity due to a
hip fracture that occurred shortly after surgery and another patient died of a rare post-surgical
complication. Two patients disclosed at the six-week follow-up visit that they did not participate
or document their activity during the study period. One of these participants reported he had a
bad hip and experienced pain with walking. The other participant reported significant abdominal
pain and lower extremity edema and had recently undergone a stent placement procedure for
biliary anastomosis stricture post-transplant. Of the 12 patients who consented for the study,
eight or 66%, completed the six week physical activity study period.
Demographics of the study sample are listed in Table 4. Two women and six men (n = 8)
participants ranged in age from 51 to 63 years of age at time of recruitment. Disease related
indications for transplant included: chronic hepatitis C (n = 3), Caroli’s disease (n = 1), fatty
liver disease (n = 1), alcohol abuse (n = 2), cholangiocarcinoma (n = 1), and hepatocellular
carcinoma (n = 3). Two participants had hepatitis C along with hepatocellular carcinoma, and
one participant had hepatitis C, hepatocellular carcinoma, and alcohol abuse. The average Model

26

for End-Stage Liver Disease (MELD) score was 25 (on a scale of 18-40) at the time of
transplant. The participants had one-to-two major comorbidities with the most common being
hypertension and kidney disease. One patient was hospitalized for complications prior to
receiving a liver transplant while three patients required an ICU stay during their hospitalization.
Mean length of hospital stay averaged seven days (SD = 4.05) with median length being five
days.
Table 4
Patient Demographics & Acuity
n
Total

8
Men

6 (75%)

Women

2 (25%)

Average Age in Years

M (SD)
Median

60.37 years (±3.96)
62 years

Average # of Comorbidities

1.87 (0.78)
2 conditions

Pre-surgery hospitalization due to
complications

1 (12.5%)

ICU Stay

3 (37.5%)

Average Length of Stay in Days

7 days (±4.05)
5 days

MELD Score at time of transplant
(Model for End-Stage Liver Disease)

25.375 (± 7.07)
24.5
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Physical Activity
Each participant answered seven questions about their physical activity from the IPAQ at
baseline (T1) and at six weeks (T2). A MET score was calculated for T1 and T2 based on the
IPAQ formula. Patients scores ranged from 99 MET to 14,826 MET at T1 with median of 407.5
MET. Scores at T2 ranged from 462 MET to 2,479 MET with a median score of 1711.5 MET.
Since the data was not normally distributed, the nonparametric Wilcoxon Matched-Pairs Signed
Ranks Test was used (McCrum-Gardner, 2007). This test retained the null hypothesis that the
median of differences between T1 and T2 MET scores equals 0 even though median scores
increased from 407.5 MET to 1,711.5MET or 420% overall.
Two participants’ MET scores were noted to be outliers. One of these participants
reported eight hours of painting (which classified as moderate activity) seven days per week at
baseline just prior to his transplant surgery. He also reported suffering a deep venous thrombosis
(DVT) about 25 days post-operatively that precluded him from walking more than 15 minutes
per day thereafter. The other participant reported 45 minutes of vigorous activity seven days per
week at baseline, as well as 30 minutes of moderate activity seven days per week.
All eight of the study patients kept a daily log of the number of minutes of physical
activity that they completed each day through the first six weeks post hospital discharge. Mean
and median minutes per day for the 42 days are displayed in Figure 1. The graph suggests that
the minutes of physical activity gradually increase over time although during some time periods
it seems that minutes decrease. This trend is important to consider when determining the
appropriate time intervals to evaluate physical activity and perhaps provide insight into when
clinical prompts may be useful to encourage the activity.
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Figure 1
Minutes of Daily Physical Activity over Six Weeks
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Quality of Life
Each participant was asked their perception of QOL at T1 and T2 in lieu of burdening
very ill patients with the longer SF-12 instrument. Participants reported their perceived QOL
using a scale of 1-10, with 1 being the worst and 10 being the best. The participants gave a range
of answers from 2 to 10 at T1 with an average score of 5.5 (SD = 2.51) and median of 5. The
range of QOL responses at T2 had risen to between 5 and 10 with an average score of 8.25 (SD =
1.67) and median of 8.5. The Wilcoxon Matched-Pairs Signed Ranks Test rejected the null
hypothesis (that median of differences between T1 and T2 equaled 0) supporting significant
improvement in QOL scores (P = 0.27).
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Chapter Five: Discussion
The project set out to discover if adult liver transplant patients who are provided with
physical activity (walking) instructions would increase their physical activity from baseline to six
weeks. The project also sought out to answer three secondary questions: 1) Will adult liver
transplant patients document their daily physical activity on an activity log? 2) Will adult liver
transplant patients who participate in this walking program perceive an increased QOL from
baseline to six weeks? 3) What is the optimal time following liver transplant to start a walking
program?
Participant Demographics
The participants in this project had an average age of 60 years with a median age of 62
years. This fits with the general population of liver transplant recipients, where 62.7% are aged
50-64 years (OPTN/SRTR Annual Data Report, 2012). In addition, in the general population the
most common diagnosis necessitating transplant in 2012 was hepatitis C, with a progressively
rising number of patients with malignancy. This aligns with this project’s cohort, with three
participants carrying a hepatitis C diagnosis and three participants with hepatocellular carcinoma.
Median MELD score for liver transplant recipients in 2012 was 25 nationwide. This also aligns
with this project’s participants, who had an average MELD score of 25 with a median of 24.5.
Physical Activity
The project’s primary goal of increasing physical activity in liver transplant patients was,
indeed, met. Participants’ walking minutes gradually increased over the six-week time period.
Of note, patients have physical activity restrictions after surgery and are instructed at discharge
not to engage in vigorous aerobic activity; however, walking is encouraged. This may explain
why at baseline some participants reported higher MET scores than at six weeks and, thus, why
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there was not a significant increase in MET scores from T1 to T2. However, we cannot discount
the clinical significance of walking.
It is also notable to understand why there seemed to be a downward trend of minutes
walked at the three-week mark. Participants must undergo labs, clinic visit, staple removal, and
extra testing with Doppler ultrasound and cholangiogram around the 21-day mark. After that
time, if there are no complications, patients are typically “discharged” from the clinic other than
weekly labs until the four-month mark. This explains why it seems there is a dip in activity
around three weeks with subsequent increase in activity thereafter. This has ramifications for
future studies in how data collection start and stop times are configured.
Documentation
One of the secondary goals of the project was to improve documentation of activity by
supplying the participants with an activity log to keep track of the minutes walked each day. Ten
out of the original 12 participants did, in fact, fill out their activity logs each day (this includes
the two participants who suffered complications). Of the two participants who did not document
their minutes walked, one reported he had a bad hip and that it was too painful to walk. Perhaps
when evaluating potential candidates for a walking program, it would be prudent to ask if they
are able to walk without significant pain. Other modalities of exercise (e.g., swimming or
biking) might be more beneficial in these cases. Also, electronic methods of recording physical
activity that allows for data downloads may be more accurate than patient self-report, as those
used in van den Berg-Emons et al. (2006a).
Quality of Life
Another secondary goal of the project was to answer if the participants perceived an
increased QOL from baseline to six weeks. The participants did, in fact, note a significant

31

increase in the QOL score as presented in Chapter 4. Despite the fact that the QOL question was
a very general and non-validated tool, the QOL improvement aligns with prior research studies
(Masala et al., 2012). It is uncertain, however, if the walking program was related to the
improvement in QOL or whether other factors played a role. It is reasonable, however, to
surmise that physical activity, which has been shown to be significantly correlated with
improved QOL in prior research, is highly beneficial in the liver transplant population.
Timing of Walking Program
The last secondary goal of the project was to determine the optimal time following liver
transplant to start a walking program. Health care providers know that early ambulation
following surgery is critical to a speedier recovery with fewer complications. Thus, it is
important to implement a walking program early on in a patient’s recovery as long as there are
no contraindications. Liver transplant recipients at this particular facility are followed twice
weekly for the first three weeks after surgery. This can prove to be a valuable opportunity to
advise and encourage patients to start a walking program and to monitor them closely. It also
serves as an important opportunity to receive real-time feedback from patients in order to
improve physical activity protocols and find new ways to motivate patients to engage in activity.
Strengths and Limitations
This project was a pilot project with a small convenience sample of patients. The goal of
the project was not to generate new research or evidence, but to apply the evidence that already
exists regarding physical activity in liver transplant patients. In this regard, the project was
successful, with 10 out of 12 (83%) participants following through with recording their walking
activity at least part of the six weeks and with 8 out of 12 (66.6%) participants recording their
walking the entire six weeks.
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Implications for Practice
It is important to find ways to enhance QOL and fulfill the dreams of those who may
have waited sometimes years for their new organ. There is consistent evidence that liver
transplant patients who engage in regular physical activity have improved QOL. Providing liver
transplant patients with specific walking instructions and an activity log to keep track of their
walking can serve as an effective strategy to motivate patients to increase their activity. With
extensive resources (that is, professional, technical, financial, and emotional) utilized to bring
each liver transplant into fruition, clinicians must commit themselves to optimizing each
patient’s QOL and clinical outcomes.
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Table 1
Studies Investigating Physical Activity and Quality of Life in Liver Transplant Patients
Author
(Date)
Krasnoff, et
al.
(2006)

Design

Sample

Outcome

Intervention

RCT

119 transplant
patients at 2, 6, and
12 months post OLT

Treadmill
exercise test,
muscle strength
test, body
composition
assessment,
nutrition
assessment and
HRQOL

Exercise prescription
and dietary
recommendations

Masala, et al.
(2012)

Case control

54 patients 1-8 years
post transplant and
108 controls

Questionnaires: SF-36
and IPAQ

Painter, et al.
(2001)

Cross-sectional

180 patients >5
years post transplant

QOL and
physical
activity/metabolic
equivalent score
Health-related
QOL

Rongies, et
al. (2011)

Cross-sectional

26 randomlyselected patients >5
years post transplant
divided into two
groups according to
level of exercise

Health-related
QOL

Questionnaire SF-36

Questionnaire SF-36

Results

Limitations

Significant group by time
interaction in the General
Health and Mental Health
scales of the SF-36 for the
intervention group, with
non-significant
improvement in the
Vitality and Social
Functioning scales.
Significant group by time
interaction in exercise
capacity, age-predicted
VO2 peak, and reduced
percent of fat calories for
the intervention group
Metabolic equivalent was
significantly positively
correlated with all SF-36
scales.
Those who engaged in
regular exercise had
significantly higher scores
on the 4 physical scales,
the Vitality scale, and the
Physical Composite scale
of the SF-36.
Those who engaged in
regular exercise had
significantly higher scores
on most of the SF-36
scales as compared to their
sedentary counterparts.

Not blinded;
only 37% adhered
to both nutrition
and exercise
recommendations;
21.2% dropout
rate; home-based
program was low
in intensity

Opportunistic
sample; small
sample size
Only 59%
returned
questionnaires

Small sample size
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Author
(Date)
van den
Berg-Emons,
et al. (2006a)

Design

Sample

Outcome

Intervention

Cross-sectional
case control

8 transplant patients
6-36 months after
transplant and 8
matched persons
without known
health issues

Level of physical
activity, fatigue,
and health-related
QOL

Measurement of
activity using an
accelerometry activity
monitor on two
consecutive weekdays

van
Ginneken, et
al. (2007)

Cross-sectional

18 patients 1-5 years
post transplant

Physical fitness,
severity of
fatigue, and
health-related
QOL

6-minute walk test,
questionnaires,
measurement of body
composition, strength
test, and aerobic test

van
Ginneken, et
al. (2010)

Uncontrolled
interventional/prepost

18 fatigued patients
1-17 years post
transplant

Health-related
QOL

12-week supervised
aerobic and strength
training exercise
program and individual
counseling sessions

Results

Limitations

Significant correlation
between activity level and
Physical Functioning,
Role-Emotional, and
Mental Health scales the
RAND-36. Significant
inverse correlation
between duration and
intensity of activity and
fatigue severity.
Significant correlation
between cardiorespiratory
fitness and Physical
Functioning, Social
Functioning, and Vitality
scales of the RAND-36.
Significant inverse
correlation between
cardiorespiratory fitness
and severity of fatigue.
Significant improvement
in Physical Functioning
and Vitality scales of the
RAND-36.

Small sample size

Small sample size

Small sample
size, no control
group
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Table 3
Significant Improvement in QOL per scale of the SF-36/RAND-36 for each study
SF-36/RAND-36 Scales Krasnoff et al. Masala et al. Painter et al. Rongies et al.
(2006)

(2012)

(2001)

(2011)

Physical Functioning

X

X

X

Role – Physical

X

X

Bodily Pain

X

X

X

X

X

X

Vitality

X

X

Social Functioning

X

X

Role – Emotional

X

X

General Health

Mental Health

X

X

X

Mental Composite

X

X

X

X
X

van Ginneken
et al. (2010)

X

X

X
X
X

X

van Ginneken
et al. (2007)

X

X

Physical Composite

van den
Berg-Emons
et al. (2006a)

X
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Appendix A

RESEARCH PARTICIPANT CONSENT AND PRIVACY
AUTHORIZATION FORM
Study Title: Increasing Physical Activity in Post Liver Transplant Patients
IRB#:

13-004699

Principal Investigator: Jennifer Serotta, ARNP, FNP-BC and Colleagues
Please read this information carefully. It tells you important things about this research study. A
member of our research team will talk to you about taking part in this research study. If you
have questions at any time, please ask us.
Take your time to decide. Feel free to discuss the study with your family, friends, and healthcare
provider before you make your decision.
To help you decide if you want to take part in this study, you should know:
 Taking part in this study is completely voluntary.
 You can choose not to participate.
 You are free to change your mind at any time if you choose to participate.
 Your decision won’t cause any penalties or loss of benefits to which you’re otherwise
entitled.
 Your decision won’t change the access to medical care you get at Mayo Clinic now or in
the future if you choose not to participate or discontinue your participation.
For purposes of this form, Mayo Clinic refers to Mayo Clinic in Arizona, Florida and Rochester,
Minnesota; Mayo Clinic Health System; and all owned and affiliated clinics, hospitals, and
entities.
If you decide to take part in this research study, you will sign this consent form to show that you
want to take part. We will give you a copy of this form to keep.
If you are signing this consent form for someone else, “you” in the consent form refers to the
participant.
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CONTACT INFORMATION

You can contact …

At …

If you have questions or about …

Principal
Investigator(s):
Jennifer Serotta

Phone:

Address:

Phone:
Mayo Clinic
Institutional Review
Board (IRB)

Toll-Free:
(866) 273-4681
Phone:

Research Subject
Advocate
(The RSA is independent
of the Study Team)

Toll-Free:
(866) 273-4681
E-mail:

researchsubjectadvocate@mayo.edu

Research Billing

1.

 Study tests and procedures
 Research-related injuries or
emergencies
 Any research-related concerns or
complaints
 Withdrawing from the research study
 Materials you receive
 Research-related appointments
 Rights of a research participant

Florida:

 Rights of a research participant
 Any research-related concerns or
complaints
 Use of your Protected Health
Information
 Stopping your authorization to use
your Protected Health Information
 Billing or insurance related to this
research study

Why are you being asked to take part in this research study?

You are being asked to take part in this project because you are a liver transplant recipient.
Physical activity is an important part of health and well being. Increasing your physical activity
also can improve your overall quality of life. We hope to enroll 10-15 participants in this project
at Mayo Clinic Jacksonville.
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2.

Why is this research study being done?

The purpose of this project is to identify strategies that would increase physical activity among
liver transplant patients and, ultimately, improve quality of life.

3.

How long will you be in this research study?

Each participant will be in the project for four months. During these four months, the principle
investigator will meet with you three separate times: at the start of project, at six weeks, and at
four months. The project will be open for participants to enroll for approximately two months.

4.

What will happen to you while you are in this research study?

If you choose to participate, the principle investigator will ask you 7 questions about your
current level of physical activity and one question about your quality of life. Information about
your gender, age, MELD score, medical diagnoses, time in the hospital, and whether you
required ICU monitoring will be collected from the medical record. Physical activity walking
instructions will be given to you to follow for the next four months. An activity log to keep track
of your daily activity will be placed in your notebook. At the end of six weeks and again at four
months during routine follow-up clinic visits, you will bring your activity log that you have filled
out and answer 7 questions again regarding your physical activity and one question about your
quality of life. The rest of your care at the clinic will not be changed in any way. If you have
questions while you are in the project, you will be free to call the clinic, and the investigator will
call you back to offer assistance.

5.

What are the possible risks or discomforts from being in this
research study?

There is minimal risk for participating in this project. Participants may feel fatigue from walking,
muscle fatigue, or mild shortness of breath; however, these should subside once the activity
ceases. If you feel any unusual discomfort, excessive fatigue, pain, shortness of breath, chest
pain, fever or abdominal pain, then you should stop walking and rest. You are advised to call the
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clinic with any of these unexpected symptoms and may need to either adjust your activity or
withdraw from the project.

6.

Are there reasons you might leave this research study early?

Taking part in this project is voluntary. You may decide to stop at any time. You should tell the
investigator if you decide to stop participating in the project.
In addition, the investigator may stop you from taking part in this project at any time if:
*
You have fever, if you are clinically unstable, if you have an active
infection, and/or recommendation by your physician to stop the walking program.
*
If the project is stopped for an unexpected reason.

7.

What are the possible benefits from being in this research study?

The benefits of participating in this study may include increasing your daily physical activity
which has many known health benefits. Learning about the best ways we can implement an
exercise/walking program for our liver transplant patients following surgery is another benefit of
this project.

8.

What alternative do you have if you choose not to participate
in this research study?

You do not have to be in this project to receive your usual transplant care. You may withdraw
from the project and/or refuse to speak with the principle investigator at any point during the
project.

9.

Will you be paid for taking part in this research study?

You will not be paid for taking part in this project.

40

10.

How will your privacy and the confidentiality of your records be protected?

Mayo Clinic is committed to protecting the confidentiality of information obtained about you in
connection with this research study. Your privacy is important to us, and we want to protect it as
much as possible. By signing this form, you authorize Mayo Clinic and the investigator to use
any information created or collected in the course of the project. This information will be kept in
a locked cabinet when not being worked with to analyze the findings of the project. If some of
the information is reported in published medical or nursing journals or scientific discussions, it
will be done in a way that does not directly identify you. Each participant will be assigned a
unique identifier number which will protect your identity once the project is concluded. This
authorization lasts until the end of the project.
During this research, information about your health will be collected. Under Federal law called
the Privacy Rule, health information is private. However, there are exceptions to this rule, and
you should know who may be able to see, use and share your health information for research and
why they may need to do so. Information about you and your health cannot be used in this
research study without your written permission. If you sign this form, it will provide that
permission.
Health information may be collected about you from:
 Past, present and future medical records.
 Research procedures, including research office visits, tests, interviews and
questionnaires.
Why will this information be used and/or given to others?
 To do the research.
 To report the results.
 To see if the research was done correctly.
If the results of this study are made public, information that identifies you will not be used.
Who may use or share your health information?
 Mayo Clinic research staff involved in this study.
With whom may your health information be shared?
 The Mayo Clinic Institutional Review Board that oversees the research.
 Other Mayo Clinic physicians involved in your clinical care.
 A group that oversees the data (study information) and safety of this research.
Is your health information protected after it has been shared with others?
Mayo Clinic asks anyone who receives your health information from us to protect your privacy;
however, once your information is shared outside Mayo Clinic, we cannot promise that it will
remain private and it may no longer be protected by the Privacy Rule.
Your Privacy Rights
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You do not have to sign this form, but if you do not, you cannot take part in this research study.
If you cancel your permission to use or share your health information, your participation in this
study will end and no more information about you will be collected; however, information
already collected about you in the study may continue to be used.
If you choose not to take part or if you withdraw from this study, it will not harm your
relationship with your own doctors or with Mayo Clinic.
You can cancel your permission to use or share your health information at any time by sending a
letter to the address below:
Mayo Clinic
Office for Human Research Protection
ATTN: Notice of Revocation of Authorization
200 1st Street SW
Rochester, MN 55905
Alternatively, you may cancel your permission by emailing the Mayo Clinic Research Subject
Advocate at: researchsubjectadvocate@mayo.edu
Please be sure to include in your letter or email:
 The name of the Principal Investigator,
 The study IRB number and /or study name, and
 Your contact information.
Your permission lasts until the end of this study, unless you cancel it. Because research is an
ongoing process, we cannot give you an exact date when the study will end.
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ENROLLMENT AND PERMISSION SIGNATURES:
Your signature documents your permission to take part in this research.
Printed Name

/
/
Date

:
Time

AM/PM

_______________________________
Signature
Person Obtaining Consent I have explained the research study to the participant.
 I have answered all questions about this research study to the best of my ability.
Printed Name
_______________________________
Signature

/
/
Date

:
Time

AM/PM
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Appendix B
Physical Activity Recommendations for
Liver Transplant Patients
Prior to discharge from the hospital following liver transplant, the care provider (e.g., Nurse
Practitioner, Physician Assistant, Clinic or Hospital RN Coordinator) will utilize the Five A's
Behavior Change Model (Assess, Advise, Agree, Assist and Arrange) (Registered Nurses’
Association of Ontario, 2010) as a guide to help motivate patients to incorporate a walking
program into their daily activity.
Assess Current Level of Physical Activity
Care Provider will say:
"Good morning, Mr. Jones. I would like to talk to you about the health benefits of engaging in
regular exercise. Some of the benefits include lowering blood pressure, improving blood sugar
levels, improving stamina, reducing fatigue, and improving overall quality of life. I have a few
simple questions to ask you in order to find out how much exercise you are currently doing on a
daily basis."
At this time, the International Physical Activity Questionnaire (IPAQ) is administered to the
patient. The care provider will ask each of the 7 questions orally and record the answers on the
IPAQ sheet. One quality of life (QOL) question will be asked after the IPAQ questions: "On a
scale of 0-10 with 0 being the worst and 10 being the best,, what would you say is your quality of
life at this time?" This number will be recorded on an attachment to the IPAQ sheet.
Advise and Agree to Engage in Physical Activity
Care Provider will say:
"According to the American Heart Association, it is best to engage in 150 minutes per week of
moderate exercise in order to maximize our health. They state that walking is one of the best
ways to incorporate physical activity into our daily routines. We would like to provide you with
physical activity (walking) instructions:
Walk 5-10 minutes each day. Increase your walking by 5 minutes every 3 days. Your
goal is to reach 30 minutes of walking for at least 5 days per week.
"Does that seem like something that you could incorporate into your routine? Do you have any
concerns or questions about engaging in a walking program?".
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Assist Patient to Incorporate a Walking Program
Care Provider will say:
"I have a daily activity log that where you can keep track of your daily walking as you work to
increase your physical activity. This can help you set mini goals for yourself and see the
progress you are making each day. You may monitor your pulse either at your neck or wrist by
counting for 15 seconds and multiplying by 4 to obtain your beats per minute. A safe target
range is 60-120 beats per minute. As you can see on the sheet, be aware of certain warning signs
such as excessive fatigue, pain, or shortness of breath. If you experience any of these while
walking, you should stop walking and rest. If your symptoms continue long after you've stopped
walking, please call the clinic for further advice, as your walking program may need to be
adjusted. If it is after hours, you will be able to speak to the Liver Transplant on call provider
who can give you further instruction. If you are having severe symptoms of shortness of breath
or chest pain, you should go to the Emergency Room to be evaluated."
The care provider shows the patient how to fill out the activity log and places this in the patient's
notebook.
Arrange for follow-up
Care Provider will say:
"You are welcome to call the clinic at any time should you have any questions or concerns about
your walking program. Your clinic nurse or provider will periodically check to see how you’re
getting along with your walking program so be sure to bring your log book with you to your
appointments. Then after six weeks during one of your follow-up appointments, we will ask you
to answer questions about your activity level and quality of life just as you did today. Do you
have any questions?"
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Appendix C
*There are many health benefits of engaging in regular exercise. Some of the benefits include
lowering blood pressure, improving blood sugar levels, improving stamina, reducing fatigue, and
improving quality of life. If you have excessive fatigue, pain, or shortness of breath, then stop
exercising and rest. You may break up your walks into shorter segments throughout the day.
Date/Day of Week

Physical Activity Log

Put number of minutes walked in each space

Sun

Mon

Tues

Wed

Thurs

Fri

Sat

Sun

Mon

Tues

Wed

Thurs

Fri

Sat

Wed

Thurs

Sun

Mon

Tues

Sun

Mon

Tues

Wed

Tues

Wed

Fri

Sat

Thurs

Fri

Sat

Thurs

Fri

Sat

Sun

Mon

Sun

Mon

Tues

Wed

Thurs

Fri

Sat

Sun

Mon

Tues

Wed

Thurs

Fri

Sat
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